Spero Therapeutics

+$0.10 (+0.52%) Today
$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SPRO and other ETFs, options, and stocks.

About SPRO

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant, or MDR, bacterial infections. Its pipeline product candidates include SPR994, SPR741, and SPR206.

CEO
Ankit A. Mahadevia
Employees
89
Headquarters
Cambridge, Massachusetts
Founded
2013

SPRO Key Statistics

Market Cap
615.61M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
115.88K
High Today
$19.78
Low Today
$18.92
Open Price
$19.09
Volume
411.89K
52 Week High
$23.64
52 Week Low
$9.25

SPRO News

Simply Wall StSep 14

Spero Therapeutics pops 12% this week, taking one-year gains to 87%

The simplest way to invest in stocks is to buy exchange traded funds. But one can do better than that by picking better than average stocks (as part of a divers

SPRO Earnings

-$1.32
-$0.88
-$0.44
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure